SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-058529
Filing Date
2023-05-10
Accepted
2023-05-10 17:17:23
Documents
14
Period of Report
2023-05-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315272d1_8k.htm   iXBRL 8-K 28115
2 EXHIBIT 3.1 tm2315272d1_ex3-1.htm EX-3.1 6397
3 EXHIBIT 99.1 tm2315272d1_ex99-1.htm EX-99.1 11165
  Complete submission text file 0001104659-23-058529.txt   229293

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hepa-20230510.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20230510_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20230510_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2315272d1_8k_htm.xml XML 3696
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 23907717
SIC: 2834 Pharmaceutical Preparations